The largest database of trusted experimental protocols

2 protocols using l name hydrochloride

1

Cytokine-Induced Cancer Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fully authenticated human NCI-60 cancer cell lines (NCI, Bethesda, MD, USA) used in this study were cultured in RPMI media (Corning, 10–040-CV) supplemented with 10% FBS and 1% penicillin and streptomycin. Cancer cells were seeded a day before stimulation. On the day of stimulation, the cells were washed once with warm and sterile DPBS, followed by treatment with different cytokines for 48 h. The concentration of the cytokines used were 25 ng/mL of IL-6 (Peprotech, 200-06), IL-8 (Peprotech, 200-08M), IL-18 (R&D, B001-5), IL-15 (Peprotech, 200-15), IL-1α (Peprotech, 200-01A), IL-1β (Peprotech, 200-01B), IL-2 (Peprotech, 200-02), TNF-α (Peprotech, 300-01A), IFN-γ (Peprotech, 300-02). For the inhibition of nitric oxide (NO), cancer cells were co-treated with 1 mM of L-NAME hydrochloride (TOCRIS, 0665) or 100 μM of 1400W dihydrochloride (Enzo Life Sciences, ALX-270–073-M005) along with the cytokines. For inhibition of the JAK signaling pathway, the cancer cells were co-treated with 5 μM of baricitinib (Achemblock, K12360) all through the experiment.
+ Open protocol
+ Expand
2

Cytokine-Stimulated Macrophage Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMDMs were stimulated with the following cytokines where indicated unless otherwise noted: 20 ng/mL of IL-6 (Peprotech, 212–16), 10 ng/mL of IL-18 (BioLegend, 767004), 20 ng/mL of IL-15 (R&D, 447-ML), 20 ng/mL of IL-1α (Peprotech, 200–01A), 20 ng/mL of IL-1β (R&D, 201-LB-025), 20 ng/mL of IL-2 (Peprotech, 212–12), 25 ng/mL of TNF-α (Peprotech, 315–01A), 50 ng/mL of IFN-γ (Peprotech, 315–05), 50 ng/mL of IFN-α (PBL Assay, 12106–1), 50 ng/mL of IFN-β (PBL Assay, 12400–1), or 50 ng/mL of IFN-λ (Peprotech, 250–33). For human cells, 50 ng/mL of TNF-α (Peprotech, AF-300–01A) and 100 ng/mL of IFN-γ (Peprotech, 300–02) was used for the indicated time. For the inhibition of NO, cells were co-treated with 1 mM of L-NAME hydrochloride (TOCRIS, 0665) or 100 μM of 1400W dihydrochloride (Enzo Life Sciences, ALX-270–073-M005). SIN-1 chloride (TOCRIS, 0750) at the indicated concentrations was used as the NO donor.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!